Healthcare Stocks
Filings and news across 7 industries · newest 2:30 PM ET · How scores work
Sun, Oct 112 events
8BBIOBridgeBio Pharma, Inc.Acoramidis Cuts Hospitalizations 27% vs Tafamidis in Largest EHR Study8BBIOBridgeBio Pharma, Inc.Encaleret Phase 3 Data Show 100% Symptom Improvement in ADH1; RECLAIM-HP Doses First Patient
Sat, Oct 101 event
Fri, Oct 937 events
7IARTIntegra LifeSciences Holdings CorpIntegra Prices $450M Senior Secured Notes at 9.5% in Refinancing8SBFMSunshine Biopharma Inc.Sunshine Biopharma Closes $6M Unit Offering — 43.6M Warrant Shares Loom Over 4.3M Outstanding8SBFMSunshine Biopharma Inc.Sunshine Biopharma Finalizes $6M Unit Offering at $0.55 — 43.6M Warrant Shares Loom7IARTIntegra LifeSciences Holdings CorpIntegra Prices $450M Senior Secured Notes at 9.5% to Refinance Debt9LABStandard BioTools Inc.Standard BioTools Files Final Proxy for Treeline Reverse Merger — 84% Dilution, 1-for-20 to 1-for-40 Reverse Split9STEXStreamex Corp.Streamex Receives Nasdaq Delisting Notice for Sub-$1 Bid Price7VTGNVistagen Therapeutics, Inc.Vistagen Expands Executive Severance Plan to Cover Terminations Without Change in Control8ARTLARTELO BIOSCIENCES, INC.Artelo Flags Nasdaq $5M MVLS Delisting Risk, Weighs More Dilutive Financing7MBRXMoleculin Biotech, Inc.Moleculin Stockholders Approve Reverse Split Authority and 3.86M Share Plan Expansion7QUCYQuantum Cyber N.V.Quantum Cyber Launches $100M ATM Program with Titan Partners7ISPCiSpecimen Inc.iSpecimen Lowers Reverse-Split Vote Bar to Plurality, Adjourns to Oct 307CLGNCollPlant Biotechnologies LtdCollPlant Secures $3.7M Private Placement to Advance LightSolver Supercomputing7PYXSPyxis Oncology, Inc.Pyxis Oncology Seeks Approval to Double Authorized Shares to 380M to Cover Warrant Exercises8SSIISS Innovations International, Inc.SS Innovations Secures $20M via Secured Convertible Note with Variable-Price Conversion7SINTSintx Technologies, Inc.SINTX Raises $2.0M from Class B Warrant Exercises, Adds 651K Shares8SXTCChina SXT Pharmaceuticals, Inc.China SXT Closes $12M Offering With Zero-Price Warrants and $12M Over-Allotment Option8PFSAProfusa, Inc.Profusa Swaps Auditors Amid Unremediated Material Weaknesses and Going Concern Doubts8JSPRJasper Therapeutics, Inc.Jasper Seeks Approval to Convert 604M Preferred Shares — 95% Dilution for Existing Holders8PCVXVaxcyte, Inc.Vaxcyte Closes Upsized $1.1B Concurrent Offerings After Full Over-Allotment Exercise8VREOFVireo Growth Inc.Vireo Growth Files S-4 for Planet 13 Merger: 5.16M Shares, $51.8M Deal Value8BIAFbioAffinity Technologies, Inc.bioAffinity Closes $4M Registered Direct Offering and Suspends ATM7ISPCiSpecimen Inc.iSpecimen Shareholders Approve Dilutive Financing and Foldlab Deal; Reverse Split Vote Delayed to Oct 308CTRVPHepion Pharmaceuticals, Inc.Hepion Acquires Gravitas Life Sciences in $4.25M Related-Party Deal, Names New CEO and CFO9TCRTAlaunos Therapeutics, Inc.Nasdaq Moves to Delist Alaunos Therapeutics Over Equity Shortfall8PHGKoninklijke Philips NVFDA Issues Safety Alert on Philips Lumify Ultrasound After Deaths Reported7PRGOPERRIGO Co plcCVC Capital Reportedly Eyeing Perrigo Takeover to Combine with Cooper Consumer Health7XRAYDENTSPLY SIRONA Inc.Dentsply Sirona Amends Credit Agreements to Loosen Leverage Covenants Through 20269BGMSBio Green Med Solution, Inc.BGMS Mails Definitive Proxy for $2B Reverse Merger with Future NRG — Vote Set for Nov 197PCSAProcessa Pharmaceuticals, Inc.Processa Seeks Reverse Split Approval to Meet Nasdaq $4.00 Listing Requirement7PCSAProcessa Pharmaceuticals, Inc.Processa Registers 306.6M Shares for Resale by PIPE and Merger Investors7MGRXMangoceuticals, Inc.Mangoceuticals Closes $500K Offering at 74% Premium to Market7MGRXMangoceuticals, Inc.Mangoceuticals Secures $493K via Registered Direct Offering at $0.75 per Unit8LNAILunai Bioworks Inc.Lunai Bioworks Requests Nasdaq Trading Suspension Amid Alleged Short-Selling Abuses7RTSNRetension Pharmaceuticals, Inc.Retension Pharma Slides 14% in Debut After $45M IPO Priced at $128BIAFbioAffinity Technologies, Inc.bioAffinity Prices $4M Registered Direct Offering at $6.122 with Warrants7TEVATeva Pharmaceutical Industries LtdTeva Wins FDA Approval for Monthly Schizophrenia Injection7SBFMSunshine Biopharma Inc.Sunshine Biopharma Closes $6M Offering at $0.55, Down from $0.6876 Announced
How Wiseek picks and scores these
How Wiseek curates this list
Every item here is a high-importance (score ≥ 7) SEC filing or licensed news event for a healthcare company, sourced from SEC EDGAR and licensed news wires and ranked by Wiseek's 1–10 importance score. The underlying source is linked from each article. See our methodology and editorial policy.